EUDA Cash Conversion Cycle from 2010 to 2026

EUDA Stock   0.89  0  0.51%   
EUDA Health's Cash Conversion Cycle is increasing over the years with slightly volatile fluctuation. Overall, Cash Conversion Cycle is expected to go to 25.59 this year. From 2010 to 2026 EUDA Health Cash Conversion Cycle quarterly data regression line had arithmetic mean of (25.06) and r-squared of  0.41. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
24.37
Current Value
25.59
Quarterly Volatility
33.82150781
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check EUDA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EUDA Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 164.6 K, Interest Expense of 56.8 K or Selling General Administrative of 4.1 M, as well as many indicators such as Price To Sales Ratio of 34.18, Dividend Yield of 0.0 or Days Sales Outstanding of 16.93. EUDA financial statements analysis is a perfect complement when working with EUDA Health Valuation or Volatility modules.
  
Build AI portfolio with EUDA Stock
Check out the analysis of EUDA Health Correlation against competitors.
Analyzing EUDA Health's Cash Conversion Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Cash Conversion Cycle has evolved provides context for assessing EUDA Health's current valuation and future prospects.

Latest EUDA Health's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of EUDA Health Holdings over the last few years. It is EUDA Health's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

EUDA Cash Conversion Cycle Regression Statistics

Arithmetic Mean(25.06)
Geometric Mean36.50
Coefficient Of Variation(134.94)
Mean Deviation28.48
Median(41.73)
Standard Deviation33.82
Sample Variance1,144
Range111
R-Value0.64
Mean Square Error722.45
R-Squared0.41
Significance0.01
Slope4.28
Total Sum of Squares18,302

EUDA Cash Conversion Cycle History

2026 25.59
2025 24.37
2024 27.08
2023 23.39
2022 -83.87
2021 16.35

About EUDA Health Financial Statements

EUDA Health stakeholders use historical fundamental indicators, such as EUDA Health's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although EUDA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in EUDA Health's assets and liabilities are reflected in the revenues and expenses on EUDA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in EUDA Health Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Conversion Cycle 24.37  25.59 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:
Check out the analysis of EUDA Health Correlation against competitors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. Projected growth potential of EUDA fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive EUDA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
0.02
Revenue Per Share
0.14
Quarterly Revenue Growth
0.602
Return On Assets
(0.64)
Understanding EUDA Health Holdings requires distinguishing between market price and book value, where the latter reflects EUDA's accounting equity. The concept of intrinsic value - what EUDA Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push EUDA Health's price substantially above or below its fundamental value.
It's important to distinguish between EUDA Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EUDA Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EUDA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.